Entering text into the input field will update the search result below

Cytokinetics prices $450M of convertible debt offering

Jul. 01, 2022 4:00 AM ETCytokinetics, Incorporated (CYTK)By: Meghavi Singh, SA News Editor

Cytokinetics, Incorporated (NASDAQ:CYTK) has priced its offering of $450.0M aggregate principal amount of 3.50% convertible senior notes due 2027.

The issuance and sale of the notes are scheduled to settle on July 6, 2022.

The initial purchasers are granted an

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.